Viewpoint
Abstract
Authors
Tobin R. Sosnick
Abstract
Authors
Michael P. McGill, David W. Threadgill
Abstract
Authors
Lóránd Váncza, Natalie J. Torok
Pragmatic reproducible research: improving the research process from raw data to results, bit by bit
Abstract
Authors
Luke V. Rasmussen, Eric W. Whitley, Leah J. Welty
Abstract
Authors
Lutfiyya N. Muhammad
Abstract
Authors
Samuel Philip Nobs, Eran Elinav
Abstract
Authors
Xi Chen, Ajit Varki
Abstract
Authors
Benjamin D. Humphreys
Abstract
Authors
Joseph Bass, Matthias H. Tschöp, Lisa R. Beutler
Abstract
This Viewpoint was written in association with the 25th anniversary of the American Society for Clinical Investigation’s (ASCI’s) Stanley J. Korsmeyer Award, which honors the highest standards of scientific excellence, meritorious research, intellectual integrity, and the mentoring of future life-science researchers. In 2018, the award recognized Joseph Heitman (Figure 1), for his key contributions to our understanding of how eukaryotic microbial pathogens evolve, cause disease, and develop drug resistance and his discovery of TOR and FKBP12 as targets of the immunosuppressive chemotherapeutic drug rapamycin. Dr. Heitman has mentored numerous undergraduates, medical students, graduate students, and postdoctoral and medical fellows, many of whom have developed independent careers in medicine and basic biomedical research.
Authors
Joseph Heitman
No posts were found with this tag.
Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)